fda compounding glp-1 warning letters october 2025 CDER Jump 50% in FY — What That Means for Industry FDA Issues Warnings Against Illegal

Overall, short-term garlic supplementation appears to effectively reduce blood pressure with minimal side effects in hypertensive patients

Real results with Glow Up Copper Peptide Patches Many users have seen significant improvements in their hair thickness, volume, and overall scalp health after using Glow Up Copper Peptide Patches consistently

The practical result: most Kaiser members now have NO weight loss GLP-1 coverage unless their employer specifically opted into the weight management rider at renewal

There are three GLP-1 FDA decisions expected in early-mid 2026 Eli Lillys Mounjaro with a new indication to reduce the risk of major adverse cardiovascular events (MACE) in patients with T2DM Eli Lillys oral once-daily orforglipron for weight loss Novo Nordisks higher dose (7.2 mg) injectable once-weekly Wegovy for weight loss Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape

How Do I Get Started with GLP-1s

Cognitive aging in black and white Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia